| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |